Europe · Wires & real time · Reuters Europe Markets

South Africa's Aspen Pharmacare to sell women's health product in Europe to Ennogen

Published by Reuters Europe Markets · United Kingdom 18 h ago

South Africa's Aspen Pharmacare will sell the European commercialisation rights and related intellectual property for its women's health ‌product Ovestin to Ennogen Healthcare…

Read the full article on Reuters Europe Markets Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.reuters.com)

Also worth reading

TASS

South Africa's Aspen Pharmacare to sell women's health product in Europe to Ennogen

Share

Also worth reading

Teenager held in basement near Kiev beaten with shovel — publication

Brent crude falls nearly 8% below $105 as US-Iran diplomacy eases supply fears

Trading Day: Oil slump no cure for AI angst

Fastmarkets clarifies China domestic steel scrap methodology guide

Binance hack plays up crypto’s trust issues

Merz says Germany must preserve 'digital sovereignty' in AI era